[Significance of tumor markers in the diagnosis and treatment of bronchial carcinoma].
In bronchogenic carcinoma a variety of tumor markers have been described in the last few years. These markers are oncofetal proteins like the carcinoembryonic antigen (CEA), pregnancy-associated antigens like the pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG), and the beta-chorionic gonadotropin (beta-HCG), or normal proteins like isoferritin, coeruloplasmin and hormones. In addition, many attempts have been made to isolate tumor-specific antigens and proteins from lung tumor tissues. The clinical application of the different tumor markers for early diagnosis, staging and therapy control of lung cancer patients is described.
D000951:Antigens, Neoplasm / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006729:Hormones, Ectopic / Q000032:analysis; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D009363:Neoplasm Proteins / Q000032:analysis; D009367:Neoplasm Staging
D000951:Antigens, Neoplasm; D001798:Blood Proteins; D002272:Carcinoembryonic Antigen; D006729:Hormones, Ectopic; D009363:Neoplasm Proteins
Bedeutung von Tumormarkern in der Diagnostik und Behandlung des Bronchialkarzinoms.